Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

Over the last decade, extensive studies have been made to understand the role played by the mammalian target of rapamycin (mTOR) in cancer. Knowledge in this field has been gained from discoveries in basic research as well as from observations made in patients treated with allosteric mTOR inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufour, Marc, Dormond-Meuwly, Anne, Demartines, Nicolas, Dormond, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757428/
https://www.ncbi.nlm.nih.gov/pubmed/24212820
http://dx.doi.org/10.3390/cancers3022478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757428/
https://www.ncbi.nlm.nih.gov/pubmed/24212820
http://dx.doi.org/10.3390/cancers3022478

Ejemplares similares